|
Real-time Estimate
Cboe BZX
11:14:35 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 107.16 USD | +0.09% |
|
+0.75% | +58.86% |
| Market Cap | 12.15B 10.43B 9.79B 8.94B 16.87B 1,159B 16.95B 116B 44.89B 585B 45.62B 44.63B 1,937B | P/E 2026 * |
14.9x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13.5B 11.58B 10.87B 9.93B 18.74B 1,287B 18.83B 129B 49.86B 649B 50.67B 49.57B 2,151B | EV / Sales 2026 * |
7.28x | EV / Sales 2027 * | 6.08x |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Halozyme Therapeutics, Inc.
| 1 day | +0.09% | ||
| 1 week | +0.75% | ||
| Current month | +29.53% | ||
| 1 month | +31.22% | ||
| 3 months | +55.74% | ||
| 6 months | +53.77% | ||
| Current year | +58.86% |
| 1 week | 105.91 |  | 109.66 |
| 1 month | 81.21 | | 109.66 |
| Current year | 61.32 | | 109.66 |
| 1 year | 61.22 | | 109.66 |
| 3 years | 32.83 | | 109.66 |
| 5 years | 29.85 | | 109.66 |
| 10 years | 8.18 | | 109.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 | Fiscal year | Chief Executive Officer | 60,000 | 0.0506% | ||
| 8/10/26 | Sell | Director | -1,626 | 0.0014% | ||
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | +0.75% | +46.10% | +151.92% | 12.15B | |
| -0.89% | +1.51% | +79.90% | +38.84% | 378B | |
| +1.14% | +1.34% | +29.42% | -13.70% | 70.23B | |
| +1.75% | +1.10% | +2.03% | -0.63% | 8.45B | |
| -2.31% | -0.94% | -16.02% | -0.35% | 5.17B | |
| -1.19% | +4.65% | -28.68% | +15.69% | 4.66B | |
| +1.34% | -11.74% | -32.42% | +8.76% | 3.03B | |
| -0.12% | -5.73% | -0.75% | +42.95% | 2.61B | |
| +2.75% | -4.05% | -15.05% | -3.95% | 2.13B | |
| -0.01% | +4.26% | +261.46% | +1,226.11% | 1.79B | |
| Average | +0.28% | -0.76% | +32.60% | +146.57% | 48.8B | |
| Weighted average by Cap. | -0.46% | +0.43% | +67.51% | +36.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 1.59B 1.49B 1.36B 2.57B 177B 2.59B 17.67B 6.85B 89.2B 6.96B 6.81B 295B | 2.05B 1.76B 1.65B 1.51B 2.85B 196B 2.86B 19.55B 7.58B 98.67B 7.7B 7.53B 327B |
| Net income | 869M 746M 700M 639M 1.21B 82.86B 1.21B 8.28B 3.21B 41.8B 3.26B 3.19B 138B | 1.07B 917M 860M 786M 1.48B 102B 1.49B 10.18B 3.95B 51.38B 4.01B 3.92B 170B |
| Net Debt | 1.34B 1.15B 1.08B 989M 1.87B 128B 1.88B 12.81B 4.97B 64.67B 5.05B 4.94B 214B | 320M 274M 257M 235M 444M 30.47B 446M 3.05B 1.18B 15.37B 1.2B 1.17B 50.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | US$106.92 | -0.14% | 258,817 |
| 26-08-26 | US$107.06 | -2.07% | 1,706,117 |
| 26-08-25 | US$109.32 | +0.63% | 1,598,158 |
| 26-08-24 | US$108.64 | +0.43% | 2,091,282 |
| 26-08-21 | US$108.17 | +1.93% | 1,150,432 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
